IMMUNOGEN, INC.

Patent Owner

Follow Compare Add to Portfolio 2Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 110140
 
 
 
C07K PEPTIDES 7557
 
 
 
C07D HETEROCYCLIC COMPOUNDS 5496
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1084
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 10181
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 599
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 4157
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 350
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 287
 
 
 
B01D SEPARATION 1126

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0095,571 Therapeutic Combinations Comprising Anti-FOLR1 ImmunoconjugatesSep 16, 16Apr 06, 17[A61K, C07K]
2017/0050,985 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVESJul 21, 16Feb 23, 17[C07D]
2017/0050,986 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVESJul 21, 16Feb 23, 17[C07D]
2017/0051,011 METHODS OF PREPARING CYTOTOXIC BENZODIAZEPINE DERIVATIVESJul 21, 16Feb 23, 17[C07K]
2017/0044,266 CYTOTOXIC BENZODIAZEPINE DERIVATIVESJul 27, 16Feb 16, 17[C07D, A61K, C07K]
2017/0037,080 PREPARATION OF MAYTANSINOID ANTIBODY CONJUGATES BY A ONE-STEP PROCESSJul 21, 16Feb 09, 17[A61K, C07K]
2017/0029,514 ANTI-CD123 ANTIBODIES AND CONJUGATES AND DERIVATIVES THEREOFJun 28, 16Feb 02, 17[A61K, C07K]
2017/0014,522 CONJUGATES OF CYSTEINE ENGINEERED ANTIBODIESJun 28, 16Jan 19, 17[C07D, A61K, C07K]
2017/0000,900 ANTI-CD37 IMMUNOCONJUGATE AND ANTI-CD20 ANTIBODY COMBINATIONSJun 02, 16Jan 05, 17[A61K, C07K]
2017/0002,393 COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTIONDec 03, 14Jan 05, 17[C12P, C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9617270 Cytotoxic benzodiazepine derivativesFeb 13, 15Apr 11, 17[C07D, A61K]
9598490 Folate receptor 1 antibodies and immunoconjugates and uses thereofDec 15, 15Mar 21, 17[C12P, A61K, C07K]
9555125 Benzodiazepines and conjugates thereofNov 20, 14Jan 31, 17[C07D, A61K]
9550787 Benzodiazepine derivativesJan 07, 16Jan 24, 17[C07D, A61K, C07K]
9534000 Cytotoxic benzodiazepine derivatives and methods of preparationFeb 15, 12Jan 03, 17[C07D, A61K, C07K]
9518017 Purification of intermediates used in the preparation of heterobifunctional linkersJun 26, 14Dec 13, 16[C07D]
9498541 Cross-linkers and their usesMay 15, 15Nov 22, 16[C07D, A61K, C07K]
9469655 Methods for the acylation of maytansinolMar 17, 15Oct 18, 16[C07D]
9446146 Methods and agents for improving targeting of CD138 expressing tumor cellsDec 23, 08Sep 20, 16[A61K, C07K]
9447189 CD37-binding molecules and immunoconjugates thereofMar 30, 12Sep 20, 16[C12N, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0058,882 CYTOTOXIC AGENTS COMPRISING NEW ANSAMITOCIN DERIVATIVESABANMay 22, 15Mar 03, 16[C07D, A61K]
2015/0343,077 Anti-CD37 Immunoconjugate Dosing RegimensABANMay 12, 15Dec 03, 15[A61K, C07K]
2015/0306,242 PROCESS FOR PREPARING STABLE ANTIBODY MAYTANSINOID CONJUGATESABANOct 04, 13Oct 29, 15[A61K, C07K]
2015/0297,744 Anti-FOLR1 Immunoconjugate Dosing RegimensABANMar 27, 15Oct 22, 15[A61K, C07K]
2015/0110,816 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANJun 04, 14Apr 23, 15[A61K, C07K]
2015/0093,397 Methods for Increasing Efficacy of CD37-Based TherapyABANMar 29, 13Apr 02, 15[G01N, C07K]
2014/0363,451 Anti-FOLR1 Immunoconjugate Dosing RegimensABANMay 13, 14Dec 11, 14[A61K, C07K]
2014/0350,228 USE OF N-HYDROXYSUCCINIMIDE TO IMPROVE CONJUGATE STABILITYABANDec 13, 12Nov 27, 14[A61K]
2014/0212,411 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANSep 19, 13Jul 31, 14[A61K]
2014/0093,523 Anti-Integrin Immunoconjugates, Methods and UsesABANDec 04, 13Apr 03, 14[A61K]
2013/0295,050 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTSABANSep 14, 12Nov 07, 13[A61K]
2013/0108,620 METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATESABANNov 28, 11May 02, 13[A61K]
2012/0282,282 Methods for Decreasing Ocular Toxicity of Antibody Drug ConjugatesABANApr 04, 12Nov 08, 12[A61P, A61K]
2012/0269,827 Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube CancerABANMar 29, 12Oct 25, 12[A61P, A61K]
2012/0259,100 PROCESS FOR MANUFACTURING CONJUGATES OF IMPROVED HOMOGENEITYABANMar 29, 12Oct 11, 12[C07K]
2012/0226,025 METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID CONJUGATES LINKED VIA A NON-CLEAVABLE LINKER, SAID CONJUGATES AND METHODS OF MAKING SAID CONJUGATESABANMay 11, 12Sep 06, 12[C07K]
2012/0226,026 POTENT CONJUGATES AND HYDROPHILIC LINKERSABANMay 17, 12Sep 06, 12[C07D, C07K]
8137669 Elimination of heterogeneous or mixed cell population in tumorsExpiredAug 05, 08Mar 20, 12[A61K]
8093358 Methods of treatment using anti-erbb antibody-maytansinoid conjugatesWithdrawnDec 03, 07Jan 10, 12[C07K]
2011/0300,162 DRUG CONJUGATE COMPOSITIONABANAug 18, 11Dec 08, 11[A61B, A61P, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.